scholarly journals Be-Positive: Beyond Progression After Tyrosine Kinase Inhibitor in Egfr-Positive Non-Small Cell Lung Cancer (Nsclc) Patients. Preliminary Results from a Multicenter Italian Observational Study

2014 ◽  
Vol 25 ◽  
pp. iv450
Author(s):  
T. Vavala ◽  
A. Follador ◽  
M. Tiseo ◽  
D. Galetta ◽  
A. Montanino ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Observational Study ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Nsclc Patients

Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment

2019 ◽  
Vol 133 ◽  
pp. 145-159 ◽  
Author(s):  
Nishant S. Kulkarni ◽  
Vineela Parvathaneni ◽  
Snehal K. Shukla ◽  
Leonard Barasa ◽  
Jeanette C. Perron ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Quantum Dots ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung

Tyrosine Kinase Inhibitor Gold Nanoconjugates for the Treatment of Non-Small Cell Lung Cancer

2019 ◽  
Vol 11 (18) ◽  
pp. 16336-16346 ◽  
Author(s):  
Alexander M. Cryer ◽  
Cheuk Chan ◽  
Anastasia Eftychidou ◽  
Christy Maksoudian ◽  
Mohan Mahesh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Lung Cancer ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document